GlassScriptPhysician profile
Faith D Esterson
NPI 1609811983
$1,603.31
in general payments reported to CMS, 2019-2025
21 companies · $443 in 2025
The $443 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $66.78 · 2021: $159 · 2022: $207 · 2023: $179 · 2024: $373 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.54 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $247.90 | 2022-2025 | |
| Galderma Laboratories, L.P. | $185.35 | 2019-2025 | Nemluvio |
| Dermavant Sciences, INC. | $174.94 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $170.09 | 2021-2024 | Tremfya |
| Ucb, INC. | $101.83 | 2021-2025 | Bimzelx |
| Leo Pharma INC. | $94.56 | 2021-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $80.41 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $71.42 | 2019-2021 | |
| Organon LLC | $62.95 | 2025 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $61.63 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $50.43 | 2020-2025 | |
| Revance Therapeutics, INC. | $50.20 | 2024 | Daxxify |
| Almirall LLC | $44.71 | 2022 | |
| Incyte Corporation | $42.45 | 2022-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $42.08 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $30.75 | 2020 | |
| Amgen INC. | $29.50 | 2023-2025 | Otezla, Otezla |
| Lilly USA, LLC | $25.41 | 2025 | Taltz |
| Arcutis Biotherapeutics, INC. | $19.75 | 2023 | |
| Medimetriks Pharmaceuticals, INC. | $14.57 | 2019 | |
| Journey Medical Corporation | $2.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faith Esterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.